Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1978 Apr;20(1):115–119. doi: 10.1128/iai.20.1.115-119.1978

Antibody production and protection against influenza virus in immunodeficient mice.

S J Lucas, D W Barry, P Kind
PMCID: PMC421559  PMID: 307534

Abstract

The roles of T and B cells in the immune response to influenza virus were studied by using mice deficient in either T cells (athymic nude) or immunoglobulin production (CBA/N). The serological responses of these mice to either whole or disrupted A/Aichi/2/68 influenza virus vaccines were examined, and the protective effect of these inoculations was tested by challenge infection with mouse-adapted A/Aichi/2/68 influenza virus. In contrast to normal mice, neither strain of immunodeficient mouse produced detectable serum antibody after inoculation with either type of vaccine. CBA/N mice immunized with intact virus vaccine were protected, however, against subsequent lethal challenge. CBA/N mice inoculated with disrupted virus vaccine and nude mice inoculated with either disrupted or whole virus vaccine were not protected against viral challenge. Evidence of immunological memory was observed in CBA/N and nude mice that had survived live virus challenge after immunization with inactivated vaccine.

Full text

PDF
117

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amsbaugh D. F., Hansen C. T., Prescott B., Stashak P. W., Asofsky R., Baker P. J. Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. II. Relationship between IgM immunoglobulin levels and the ability to give an IgM antibody response. J Exp Med. 1974 Jun 1;139(6):1499–1512. doi: 10.1084/jem.139.6.1499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amsbaugh D. F., Hansen C. T., Prescott B., Stashak P. W., Barthold D. R., Baker P. J. Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. J Exp Med. 1972 Oct 1;136(4):931–949. doi: 10.1084/jem.136.4.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barry D. W., Mayner R. E., Staton E., Dunlap R. C., Rastogi S. C., Hannah J. E., Blackburn R. J., Nortman D. F., Graze P. R. Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man. Am J Epidemiol. 1976 Jul;104(1):34–46. doi: 10.1093/oxfordjournals.aje.a112272. [DOI] [PubMed] [Google Scholar]
  4. Barry D. W., Staton E., Mayner R. E. Inactivated influenza vaccine efficacy: diminished antigenicity of split-product vaccines in mice. Infect Immun. 1974 Dec;10(6):1329–1336. doi: 10.1128/iai.10.6.1329-1336.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burns W., Billups L. C., Notkins A. L. Thymus dependence of viral antigens. Nature. 1975 Aug 21;256(5519):654–656. doi: 10.1038/256654a0. [DOI] [PubMed] [Google Scholar]
  6. Ennis F. A., Wells M. A., Barry D. W., Daniel S., Manischewitz J. Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72. Postgrad Med J. 1976 Jun;52(608):338–344. doi: 10.1136/pgmj.52.608.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FAZEKAS de ST GROTH S., DONNELLEY M. Studies in experimental immunology of influenza. IV. The protective value of active immunization. Aust J Exp Biol Med Sci. 1950 Jan;28(1):61–75. doi: 10.1038/icb.1950.5. [DOI] [PubMed] [Google Scholar]
  8. Flanagan S. P. 'Nude', a new hairless gene with pleiotropic effects in the mouse. Genet Res. 1966 Dec;8(3):295–309. doi: 10.1017/s0016672300010168. [DOI] [PubMed] [Google Scholar]
  9. Gershwin M. E., Merchant B., Gelfand M. C., Vickers J., Steinberg A. D., Hansen C. T. The natural history and immunopathology of outbred athymic (nude) mice. Clin Immunol Immunopathol. 1975 Sep;4(3):324–340. doi: 10.1016/0090-1229(75)90002-1. [DOI] [PubMed] [Google Scholar]
  10. Gilden D. H., Cole G. A., Monjan A. A., Nathanson N. Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice. J Exp Med. 1972 Apr 1;135(4):860–873. doi: 10.1084/jem.135.4.860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hobson D., Curry R. L., Beare A. S., Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972 Dec;70(4):767–777. doi: 10.1017/s0022172400022610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hurd J., Heath R. B. Effect of cyclophosphamide on infections in mice caused by virulent and avirulent strains of influenza virus. Infect Immun. 1975 May;11(5):886–889. doi: 10.1128/iai.11.5.886-889.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jennings J. J., Rittenberg M. B. Evidence for separate subpopulations of B cells responding to T-independent and T-dependent immunogens. J Immunol. 1976 Nov;117(5 PT2):1749–1752. [PubMed] [Google Scholar]
  14. Kaye H. S., Dowdle W. R., McQueen J. L. Studies on inactivated influenza vaccines. I. The effect of dosage on antibody response and protection against homotypic and heterotypic influenza virus challenge in mice. Am J Epidemiol. 1969 Aug;90(2):162–169. doi: 10.1093/oxfordjournals.aje.a121060. [DOI] [PubMed] [Google Scholar]
  15. McLaren C., Potter C. W. Immunity to influenza in ferrets. 8. Serological response of ferrets to influenza virus vaccines after infection with heterotypic strains of influenza. Med Microbiol Immunol. 1973 Sep 26;159(1):53–62. doi: 10.1007/BF02122649. [DOI] [PubMed] [Google Scholar]
  16. McLaren C., Potter C. W., Jennings R. Immunity to influenza in ferrets. XII. Immunization of ferrets with TNBP-split influenza virus vaccine. Arch Gesamte Virusforsch. 1974;45(1-2):99–105. [PubMed] [Google Scholar]
  17. Pantelouris E. M. Absence of thymus in a mouse mutant. Nature. 1968 Jan 27;217(5126):370–371. doi: 10.1038/217370a0. [DOI] [PubMed] [Google Scholar]
  18. SEVER J. L. Application of a microtechnique to viral serological investigations. J Immunol. 1962 Mar;88:320–329. [PubMed] [Google Scholar]
  19. Scher I., Ahmed A., Strong D. M., Steinberg A. D., Paul W. E. X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells. J Exp Med. 1975 Apr 1;141(4):788–803. [PMC free article] [PubMed] [Google Scholar]
  20. Sullivan J. L., Mayner R. E., Barry D. W., Ennis F. A. Influenza virus infection in nude mice. J Infect Dis. 1976 Jan;133(1):91–94. doi: 10.1093/infdis/133.1.91. [DOI] [PubMed] [Google Scholar]
  21. Suzuki F., Oya J., Ishida N. Effect of antilymphocyte serum on influenza virus infection in mice. Proc Soc Exp Biol Med. 1974 May;146(1):78–84. doi: 10.3181/00379727-146-38047. [DOI] [PubMed] [Google Scholar]
  22. Tauraso N. M., Pedreira F. A., Spector S. L., Bernier G. M. Effect of various methods of removing non-specific inhibitors to virus hemagglutination upon serum proteins and immunoglobulins. Arch Gesamte Virusforsch. 1971;34(3):214–222. doi: 10.1007/BF01242995. [DOI] [PubMed] [Google Scholar]
  23. Virelizier J. L., Postlethwaite R., Schild G. C., Allison A. C. Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med. 1974 Dec 1;140(6):1559–1570. doi: 10.1084/jem.140.6.1559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wyde P. R., Couch R. B., Mackler B. F., Cate T. R., Levy B. M. Effects of low- and high-passage influenza virus infection in normal and nude mice. Infect Immun. 1977 Jan;15(1):221–229. doi: 10.1128/iai.15.1.221-229.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES